ACETYLSALICYLIC ACID AS SECONDARY PREVENTION IN COLORECTAL CANCER (ASAC TRIAL)
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2533651
下载链接
链接失效反馈官方服务：
资源简介：
Primary objectives: This is a multi-centre, double-blinded, randomized, placebo-controlled clinical intervention trial with acetylsalicylic acid (ASA, Trombyl) in patients undergoing liver resection for colorectal cancer liver metastasis (CRCLM). The main objective is to determine whether treatment with 160 mg ASA (Trombyl) once daily for 3 years can improve Disease FreeSurvival (DFS) in patients treated with resection for CRCLM, compared with placebo.
Primary endpoints: Time from randomisation to disease recurrence (by CT scan or MRI) or death by any cause (DFS).
创建时间：
2018-07-15
